Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
|
IN |
|
NRJ Group SA
PAR:NRG
|
FR |
|
4
|
4Basebio PLC
F:88Q
|
UK |
|
Gap Inc
NYSE:GAP
|
US |
Wall St Price Targets
KIMS Price Targets Summary
Krishna Institute of Medical Sciences Ltd
According to Wall Street analysts, the average 1-year price target for
KIMS is 849.27 INR with a low forecast of 701.95 INR and a high forecast of 1 076.25 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KIMS's stock price target?
Price Target
849.27
INR
According to Wall Street analysts, the average 1-year price target for
KIMS is 849.27 INR with a low forecast of 701.95 INR and a high forecast of 1 076.25 INR.
What is the Revenue forecast for Krishna Institute of Medical Sciences Ltd?
Projected CAGR
25%
Over the last 8 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 4 years is 25%.
What is the Gross Profit forecast for Krishna Institute of Medical Sciences Ltd?
Projected CAGR
38%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 4 years is 38%.
What is the Operating Income forecast for Krishna Institute of Medical Sciences Ltd?
Projected CAGR
25%
Over the last 8 years, the compound annual growth rate for Operating Income has been 29%. The projected CAGR for the next 4 years is 25%.
What is the Pre-Tax Income forecast for Krishna Institute of Medical Sciences Ltd?
Projected CAGR
25%
Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 34%. The projected CAGR for the next 3 years is 25%.
What is the Net Income forecast for Krishna Institute of Medical Sciences Ltd?
Projected CAGR
25%
Over the last 8 years, the compound annual growth rate for Net Income has been 36%. The projected CAGR for the next 4 years is 25%.